# India's first indigenous H5N1 bird flu vaccine for chickens to be dedicated on 20 November

URL: https://upsc.help/current-affairs/2026-11-19/h5n1-chicken-vaccine-nihsad/
Date: 19 November 2026 (2026-11-19)
Source: PIB, Government release
UPSC papers: GS3, GS2
Publisher: upsc.help (Pratidin), free and open-source UPSC Civil Services current affairs. Not affiliated with UPSC. Every fact was checked against the source reports by a separate review before publishing.

**In one line:** ICAR-NIHSAD, Bhopal has developed India's first indigenous inactivated vaccine for chickens against the H5N1 bird flu strain (clade 2.3.2.1a) that causes most Indian outbreaks.

The Ministry of Agriculture and Farmers Welfare said that Union Agriculture Minister Shivraj Singh Chouhan will dedicate to the nation, on 20 November 2026, India's first indigenous inactivated vaccine for chickens against H5N1 highly pathogenic avian influenza (HPAI) of clade 2.3.2.1a. The vaccine was developed by the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, where the event will be held. The ministry says clade 2.3.2.1a has caused most bird flu outbreaks in chickens in India, and that no specific commercial vaccine is currently available against it.

The release sets out the cost of the disease. Since India first detected H5N1 in 2006, more than 500 combined outbreaks of the H5N1 and H5N8 subtypes have been reported. Outbreaks can cause nearly 100% mortality among infected birds, and culling and trade restrictions add to farmers' losses. The 2006 outbreak caused estimated losses of ₹2,200 to 3,000 crore, and an outbreak in Manipur cost about 0.5% of the State's GDP. The ministry estimates that a major outbreak could reduce India's GDP growth by up to 1.5%, and that more than 20% of the poultry population could be at risk if the disease spreads unchecked.

There is a human health side too. The release cites WHO data of 1,003 human H5N1 cases, including 479 deaths, in 25 countries, India among them, since 2003, and says clade 2.3.2.1a has been detected in various mammals and in three human cases. H5N1 was first identified in farmed birds in southern China in 1996; human-to-human transmission has been rare. Protecting poultry thus also lowers human risk, the idea behind the One Health approach. The release does not say how the vaccine will be deployed alongside existing control measures or when it will be commercially available.

## Prelims facts

- ICAR-NIHSAD, Bhopal has developed India's first indigenous inactivated H5N1 (clade 2.3.2.1a) HPAI vaccine for chickens, to be dedicated on 20 November 2026.
- Clade 2.3.2.1a has caused most bird flu outbreaks in Indian chickens; no specific commercial vaccine existed for it.
- India has reported more than 500 H5N1 and H5N8 outbreaks since its first detection in 2006.
- WHO records 1,003 human H5N1 cases and 479 deaths in 25 countries since 2003.
- In H5N1, H stands for haemagglutinin and N for neuraminidase, two surface proteins of the virus.

## Quick recall

- **Which institute developed India's first indigenous H5N1 chicken vaccine?** ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal.
- **Which H5N1 clade does the vaccine target?** Clade 2.3.2.1a, behind most chicken outbreaks in India.
- **What type of vaccine is it?** Inactivated, made from killed virus.
- **When was H5N1 first detected in India?** 2006.
- **H5N1 and H5N8 outbreaks reported in India since 2006?** More than 500.
- **Human H5N1 cases and deaths reported to WHO since 2003?** 1,003 cases and 479 deaths in 25 countries.
- **What do H and N stand for in H5N1?** Haemagglutinin and neuraminidase, two surface proteins.
- **Where and when was H5N1 first identified?** In farmed birds in southern China, 1996.

## Prelims practice question

With reference to the vaccine for chickens announced by the Ministry of Agriculture and Farmers Welfare in November 2026, consider the following statements:
1. It is a live attenuated vaccine.
2. It targets H5N1 viruses of clade 2.3.2.1a.
3. It was developed by an institute of the Indian Council of Agricultural Research.
Which of the statements given above are correct?

(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3

Answer: (b) 2 and 3 only. Statement 1 is wrong: it is an inactivated (killed-virus) vaccine. Statements 2 and 3 are correct: it targets clade 2.3.2.1a and was developed by ICAR-NIHSAD, Bhopal.

## UPSC previous-year questions this connects to

- UPSC Mains 2019, GS3: How can biotechnology help to improve the living standards of farmers? (https://upsc.help/pyq/q360-can-biotechnology-help-improve-living-standards-farmers/)
  How to use this story in the answer: Use the indigenous bird flu vaccine as a concrete example of biotechnology shielding farmers from disease-driven income shocks.
- UPSC Mains 2015, GS3: Livestock rearing has a big potential for providing non-farm employment and income in rural areas. Discuss suggesting suitable measures to promote this sector in India. (https://upsc.help/pyq/q315-livestock-rearing-has-big-potential-providing-non-farm/)
  How to use this story in the answer: Argue that animal disease control, through measures like the new bird flu vaccine, is essential to realise the income potential of livestock rearing.
- UPSC Mains 2020, GS2: Critically examine the role of WHO in providing global health security during the COVID-19 Pandemic. (https://upsc.help/pyq/q336-role-who-providing-global-health-security-during/)

## Mains practice question

How can biotechnology protect the livelihoods of livestock farmers? Discuss with reference to India's indigenous bird flu vaccine for chickens. (250 words)

### Model answer

Poultry is a major source of rural income, and bird flu outbreaks can wipe out flocks. The indigenous inactivated H5N1 (clade 2.3.2.1a) chicken vaccine developed by ICAR-NIHSAD, Bhopal, to be dedicated on 20 November 2026, shows how biotechnology can protect farmers' livelihoods.

## How biotechnology helps farmers
- **Disease protection:** vaccines matched to local strains; India has had 500+ H5N1 and H5N8 outbreaks since 2006, with nearly 100% mortality in infected birds.
- **Income security:** fewer culls and trade curbs; the 2006 outbreak cost ₹2,200 to 3,000 crore and one in Manipur cost 0.5% of the State's GDP.
- **Indigenous capability:** no specific commercial vaccine existed for clade 2.3.2.1a; local development cuts import dependence.
- **Macro stability:** the ministry estimates a major outbreak could cut GDP growth by up to 1.5%.
- **Public health:** WHO records 1,003 human H5N1 cases and 479 deaths since 2003; reducing infection in birds lowers human risk (One Health).

## Challenges
- Strategy for use alongside culling and surveillance is not yet public.
- Cold chain and reach to small backyard farmers.
- Viruses evolve; vaccines need regular updating.

## Way forward
- Clear national vaccination protocol with continued surveillance.
- Affordable supply through cooperatives and veterinary services.
- Link with One Health data sharing between animal and human health agencies.

Strain-specific, locally made animal vaccines can turn a recurring income shock for poultry farmers into a manageable risk.

## The basics

## Why this matters

Bird flu can wipe out a poultry farm in days and, rarely, infect people. India has relied on detecting outbreaks and culling birds. On 18 November 2026 the Agriculture Ministry announced that Union Minister Shivraj Singh Chouhan would dedicate to the nation, on 20 November at ICAR-NIHSAD in Bhopal, India's first indigenous inactivated vaccine for chickens against H5N1 Highly pathogenic avian influenza of clade 2.3.2.1a, the strain behind most outbreaks in Indian chickens.

## Reading the virus's name

## The cost of outbreaks

## Why a vaccine, and why now

According to the ministry, no commercial vaccine is currently available specifically against clade 2.3.2.1a. The new product is an Inactivated vaccine, made from killed virus. Protecting birds also protects people: clade 2.3.2.1a has been found in other animals and in three human cases. That is the logic of One Health, which treats human, animal and environmental health as linked. The developer, ICAR-NIHSAD, is the Indian Council of Agricultural Research's institute for high-security animal diseases.

## Sources

- https://www.pib.gov.in/PressReleasePage.aspx?PRID=2337716&reg=3&lang=1
- https://en.wikipedia.org/wiki/Influenza_A_virus_subtype_H5N1
- https://www.nextias.com/ca/headlines-of-the-day/19-11-2026/89226
